Skip to content

Study for impairment and plasticity of extrastriate cortex in intermittent exotropia patients

Study for impairment and plasticity of extrastriate cortex in intermittent exotropia patients

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027522
Enrollment
Unknown
Registered
2019-11-17
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intermittent exotropia

Interventions

Healthy control group:nil

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Surgical treatment group: 1)Age between18 and 60 years; 2)Evidence of IXT on the basis of history and clinical examination; 3)Have surgical intention and meet the surgical indications including: loss of distant stereopsis using synoptophore and/or deflection time accounts for more than half of waking time; angle of deviation< -15?; 4)No ongoing or planned amblyopia treatment; 5)Binocular best corrected visual acuity (BCVA)=1.0, no anisometropia (binocular diopter difference < 2.5DS); 6)Right handedness; 7)Be able to understand and cooperate with examinations, sign informed consent voluntarily. Healthy control group: 1)Age between 18 and 60 years; 2)BCVA=1.0 and free of any ocular diseases; 3)Right handedness; 4)Be able to understand and cooperate with examinations, sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: Subjects who meet the inclusion criteria will be excluded if they meet any of the following criteria. 1)Have organic eye disease; 2)Previous eye surgery history; 3)Accompanied by vertical strabismus; 4)History of diseases of central nervous system and whole body; 5)Contraindication for MRI examination (treatable or accidental magnetizable metal in cardiac pacemaker or prosthesis or previous head or spinal trauma requiring neurosurgery, etc.); 6)Claustrophobia.

Design outcomes

Primary

MeasureTime frame
BOLD-fMRI;

Secondary

MeasureTime frame
ocular motility;deviation degree;Ocular dominance;distance stereopsis;accommodative convergence/accommodation (AC/A) ratio;near stereopsis;Visual perception examination;Newcastle Control Score evaluation;

Countries

China

Contacts

Public ContactFu Jing

Beijing Tongren Hospital

fu_jing@126.com+86 13801218591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026